Search for collections on Wintec Research Archive

Progress in the Development of Platelet-Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases


Full text not available from this repository. (Request a copy)


Platelet-activating factor (PAF) and its receptor (PAFr) have been implicated in a wide range of diseases and disorders that originate from the activation of inflammatory pathways. Although the exact structure of the binding site on the PAFr remains unknown, the PAFr is a well-established therapeutic target, and an array of structurally diverse PAFr antagonists have been identified. These include compounds that are structurally similar to the natural PAF ligand, synthetic heterocycles, complex polycyclic natural products, and various metal complexes.
This review provides an update on more than 20 years of progress in this area. The development and synthesis of new PAFr antagonists, structure–activity relationship studies,
the biological activity of these molecules, and their therapeutic potential are discussed.

Item Type: Journal article
Uncontrolled Keywords: inflammatory diseases, platelet-activating factor receptor, PARr
Subjects: Q Science > QR Microbiology
R Medicine > RA Public aspects of medicine
Divisions: Schools > Centre for Health & Social Practice
Depositing User: Ronan Otoole
Date Deposited: 10 Feb 2020 05:37
Last Modified: 21 Jul 2023 08:42

Actions (login required)

View Item
View Item